0

CYSTAGON از شرکت MYLAN

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CYSTAGON از شرکت MYLAN

New Drug Application (NDA): 020392

Company: MYLAN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CYSTAGON CYSTEAMINE BITARTRATE EQ 50MG BASE CAPSULE;ORAL Prescription

None

Yes No
CYSTAGON CYSTEAMINE BITARTRATE EQ 150MG BASE CAPSULE;ORAL Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/15/1994 ORIG-1 Approval

Type 1 – New Molecular Entity

PRIORITY; Orphan

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/06/2016 SUPPL-14 Manufacturing (CMC)

Label is not available on this site.

06/15/2015 SUPPL-13 Manufacturing (CMC)

Label is not available on this site.

06/06/2007 SUPPL-10 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020392s010lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020392s010ltr.pdf

01/30/2004 SUPPL-7 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20392slr007ltr.pdf

04/06/2001 SUPPL-5 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20392S5ltr.pdf

03/05/1999 SUPPL-4 Manufacturing (CMC)-Packaging

Label is not available on this site.

02/12/1998 SUPPL-3 Manufacturing (CMC)-Control

Label is not available on this site.

08/16/1996 SUPPL-2 Labeling

Label is not available on this site.

11/28/1995 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
06/06/2007 SUPPL-10

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020392s010lbl.pdf
برچسب‌ها:

نظرات کاربران

خروج از نسخه موبایل